Related Experiment Video

Updated: Aug 14, 2026

Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor (CAR) T Cell Infusions in Mice
05:22

Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor (CAR) T Cell Infusions in Mice

Published on: February 24, 2023

[The treatment of central nervous system neoplasms]

D Wójcik1, T Dyrda, W Pietras

  • 1Katedry i Kliniki Hematologii i Chorób Rozrostowych Dzieci Akademii Medycznej we Wrocławiu.

Wiadomosci Lekarskie (Warsaw, Poland : 1960)
|March 25, 2000
PubMed

Insights

This study evaluated pediatric central nervous system tumors, finding that chemotherapy and radiotherapy improved outcomes. However, local recurrences and drug toxicity remain challenges in pediatric neuro-oncology.

Area of Science:

  • Pediatric Oncology
  • Neuro-oncology
  • Clinical Research

Context:

  • This study involved 30 children (aged 1-14) diagnosed with central nervous system (CNS) tumors between 1993 and 1998.
  • Tumor types included medulloblastoma, ependymoma, astrocytoma, and oligodendroglioma, with some brain trunk tumors lacking histological diagnosis.
  • All patients received chemotherapy post-surgery, with additional radiotherapy for those over 3 years old.

Purpose:

  • To assess the treatment effectiveness and outcomes for pediatric patients with central nervous system tumors.
  • To evaluate the impact of chemotherapy and radiotherapy on treatment response and disease progression.
  • To identify failure rates, including local recurrences and drug toxicity, in this pediatric cohort.

Summary:

  • A cohort of 30 children with CNS tumors underwent surgery followed by chemotherapy (SIOP regimen) and radiotherapy for older children.
  • Complete resection was achieved in 13 patients; treatment effectiveness was monitored via neurological exams and imaging.
  • Failure occurred in 10 patients due to local recurrences and 1 due to drug toxicity, with 17 remaining under observation.

Impact:

  • Highlights the challenges of local recurrences and drug toxicity in pediatric CNS tumor treatment.
  • Provides insights into the management and outcomes of diverse pediatric brain tumors.
  • Informs future therapeutic strategies and follow-up protocols for young patients with CNS malignancies.

More Related Videos

Surgical Transplantation of Tumor Cells into the Spinal Cord of Mice05:39

Surgical Transplantation of Tumor Cells into the Spinal Cord of Mice

Published on: December 27, 2024

Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis09:33

Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis

Published on: March 20, 2026

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...